Mo'men Aldalal'ah - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Digital Health|September 15, 2025

Developing and testing a smoking cessation app in Arabic language: A pilot randomized trial study protocolOla Soudah, Mo'men Aldalal'ah, Alameen Alsabbah, et al.

Vascular Health and Risk Management|February 11, 2025

Absence of Standard Modifiable Risk Factors in Middle Eastern Patients with Atherosclerotic Cardiovascular Disease. The Jordan Absence of Standard Modifiable Risk Factors (SMuRF-Less) StudyAyman J Hammoudeh, Mo'men Aldalal'ah, Elham A Smadi, et al.

Journal of Hematology|September 4, 2025

Efficacy and Safety of Momelotinib in Myelofibrosis: A Systematic Review and Meta-Analysis With a Focus on Anemia OutcomesJowan Al-Nusair, Mo'men Aldalal'ah, Mohammad Alqudah, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Digital Health|September 15, 2025

Developing and testing a smoking cessation app in Arabic language: A pilot randomized trial study protocolOla Soudah, Mo'men Aldalal'ah, Alameen Alsabbah, et al.

Vascular Health and Risk Management|February 11, 2025

Absence of Standard Modifiable Risk Factors in Middle Eastern Patients with Atherosclerotic Cardiovascular Disease. The Jordan Absence of Standard Modifiable Risk Factors (SMuRF-Less) StudyAyman J Hammoudeh, Mo'men Aldalal'ah, Elham A Smadi, et al.

Journal of Hematology|September 4, 2025

Efficacy and Safety of Momelotinib in Myelofibrosis: A Systematic Review and Meta-Analysis With a Focus on Anemia OutcomesJowan Al-Nusair, Mo'men Aldalal'ah, Mohammad Alqudah, et al.

Pageof 1